Target intelligence / Profile preview

LLPH pseudogene 2 (LLPHP2)

Target
LLPHP2
Molecular classification
Pseudogene
01

Overview

LLPH pseudogene 2 (LLPHP2) is a non-protein-coding segment of DNA highly similar to the LLPH gene but rendered inactive by mutations. Pseudogenes such as LLPHP2 are considered "gene relics": they are often formed by duplication or retrotransposition of functional genes, then lose ability to produce functional proteins due to accumulated mutations or regulatory sequence losses[5][6]. Although most pseudogenes are considered nonfunctional, extremely rare cases exist in which a pseudogene transcript may regulate its parent gene or function as a non-coding RNA, but there is no evidence that LLPHP2 displays such regulatory functions[4][5][6]. No disease associations, drug interactions, or diagnostic use have been described for LLPHP2. LLPHP2 should not be confused with the protein-coding gene LLPH (LLP homolog, long-term synaptic facilitation factor), which is expressed in neuronal cells and does have RNA binding activity[1]. Pseudogenes can occasionally interfere with molecular assays, such as PCR, due to sequence similarity with their parent genes, but are not therapeutic targets or biomarkers[5]. LLPHP2 is a nonfunctional pseudogene, not involved in drug targeting, disease biology, or clinical monitoring[4][5][6].

Other names
LLPHP2
02

Biological functions

Other (no confirmed function; pseudogenes generally do not code for proteins and canonical functions are usually absent)
03

Disease associations

Other (no validated association with diseases or therapeutic relevance; by definition, pseudogenes do not have established roles, though rare exceptions exist for regulatory pseudogenes)

Beyond the preview

Go deeper on LLPH pseudogene 2 (LLPHP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LLPH pseudogene 2 (LLPHP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call